These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 22280405)
41. Glutamate receptors in neuroinflammatory demyelinating disease. Bolton C; Paul C Mediators Inflamm; 2006; 2006(2):93684. PubMed ID: 16883070 [TBL] [Abstract][Full Text] [Related]
42. Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination. Nathoo N; Agrawal S; Wu Y; Haylock-Jacobs S; Yong VW; Foniok T; Barnes S; Obenaus A; Dunn JF Mult Scler; 2013 May; 19(6):721-31. PubMed ID: 23027879 [TBL] [Abstract][Full Text] [Related]
43. Influence of the pineal gland on the expression of experimental allergic encephalomyelitis: possible relationship to the aquisition of multiple sclerosis. Sandyk R Int J Neurosci; 1997 Jun; 90(1-2):129-33. PubMed ID: 9285294 [TBL] [Abstract][Full Text] [Related]
44. Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of 'depression due to multiple sclerosis'. Pollak Y; Orion E; Goshen I; Ovadia H; Yirmiya R Brain Behav Immun; 2002 Oct; 16(5):533-43. PubMed ID: 12401467 [TBL] [Abstract][Full Text] [Related]
45. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090 [TBL] [Abstract][Full Text] [Related]
46. A Peptide Targeting Inflammatory CNS Lesions in the EAE Rat Model of Multiple Sclerosis. Boiziau C; Nikolski M; Mordelet E; Aussudre J; Vargas-Sanchez K; Petry KG Inflammation; 2018 Jun; 41(3):932-947. PubMed ID: 29516383 [TBL] [Abstract][Full Text] [Related]
47. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Reichardt HM; Gold R; Lühder F Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780 [TBL] [Abstract][Full Text] [Related]
48. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Owens T; Sriram S Neurol Clin; 1995 Feb; 13(1):51-73. PubMed ID: 7739505 [TBL] [Abstract][Full Text] [Related]
49. Zuo-Gui and You-Gui pills, two traditional Chinese herbal formulas, downregulated the expression of NogoA, NgR, and RhoA in rats with experimental autoimmune encephalomyelitis. Kou S; Zheng Q; Wang Y; Zhao H; Zhang Q; Li M; Qi F; Fang L; Liu L; Ouyang J; Zhao H; Wang L J Ethnopharmacol; 2014 Dec; 158 Pt A():102-12. PubMed ID: 25448504 [TBL] [Abstract][Full Text] [Related]
50. Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Di Filippo M; de Iure A; Durante V; Gaetani L; Mancini A; Sarchielli P; Calabresi P Brain Res; 2015 Sep; 1621():205-13. PubMed ID: 25498984 [TBL] [Abstract][Full Text] [Related]
51. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. Paintlia AS; Paintlia MK; Khan M; Vollmer T; Singh AK; Singh I FASEB J; 2005 Sep; 19(11):1407-21. PubMed ID: 16126908 [TBL] [Abstract][Full Text] [Related]
52. Inhibitors of tumor necrosis factor-alpha: promising agents for the treatment of multiple sclerosis? Hohlfeld R Mult Scler; 1996 Jul; 1(6):376-8. PubMed ID: 9345421 [TBL] [Abstract][Full Text] [Related]
53. Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia. Wang Y; Bi Y; Xia Z; Shi W; Li B; Li B; Chen L; Guo L Biochem Biophys Res Commun; 2018 Feb; 497(1):80-86. PubMed ID: 29407174 [TBL] [Abstract][Full Text] [Related]
54. Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis. Penkowa M; Hidalgo J J Neurosci Res; 2003 Jun; 72(5):574-86. PubMed ID: 12749022 [TBL] [Abstract][Full Text] [Related]
55. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629 [TBL] [Abstract][Full Text] [Related]
56. CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells? Agahozo MC; Peferoen L; Baker D; Amor S Mult Scler Relat Disord; 2016 Sep; 9():110-7. PubMed ID: 27645355 [TBL] [Abstract][Full Text] [Related]
57. Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis. Ghareghani M; Scavo L; Arnoult D; Zibara K; Farhadi N Fundam Clin Pharmacol; 2018 Apr; 32(2):181-187. PubMed ID: 29193274 [TBL] [Abstract][Full Text] [Related]
58. [Clinical and experimental study on multiple sclerosis with bushen gusui tablet]. Liu XY; Sun Y Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jan; 21(1):10-4. PubMed ID: 12577368 [TBL] [Abstract][Full Text] [Related]
59. Angiogenesis is regulated by angiopoietins during experimental autoimmune encephalomyelitis and is indirectly related to vascular permeability. Macmillan CJ; Starkey RJ; Easton AS J Neuropathol Exp Neurol; 2011 Dec; 70(12):1107-23. PubMed ID: 22082662 [TBL] [Abstract][Full Text] [Related]
60. Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat. Calvo P; Gouritin B; Villarroya H; Eclancher F; Giannavola C; Klein C; Andreux JP; Couvreur P Eur J Neurosci; 2002 Apr; 15(8):1317-26. PubMed ID: 11994126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]